Three switches for Germany
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Germany’s Expert Advisory Committee for Prescription has given the green light to three new prescription-to-OTC reclassifications, following a strong show of support by consumers and pharmacists for more switches in the country.
You may also be interested in...
An Expert’s Guide To Switching In Germany, Part 1: Navigating The Reclassification Process
Elmar Kroth, scientific director of the German Medicines Manufacturers´ Association, the BAH, talks exclusively to HBW Insight about prescription-to-OTC switching in Germany and the association’s efforts to improve this process.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.